Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $307.84 | 4 | 72.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $114.57 | 1 | 27.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $146.66 | 1 | $0 (2022) |
| La Jolla Pharmaceutical Company | $140.49 | 2 | $0 (2019) |
| United Therapeutics Corporation | $114.57 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $20.69 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.69 | 1 | AstraZeneca Pharmaceuticals LP ($20.69) |
| 2022 | $146.66 | 1 | ABIOMED ($146.66) |
| 2019 | $140.49 | 2 | La Jolla Pharmaceutical Company ($140.49) |
| 2018 | $114.57 | 1 | United Therapeutics Corporation ($114.57) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Respiratory | ||||||
| 05/05/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $146.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/19/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: GIAPREZA | ||||||
| 02/17/2019 | La Jolla Pharmaceutical Company | — | Food and Beverage | In-kind items and services | $121.20 | General |
| 01/25/2018 | United Therapeutics Corporation | ORENITRAM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $114.57 | General |
| Category: PAH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,359 | 2,241 | $830,948 | $194,486 |
| 2022 | 12 | 1,207 | 2,195 | $871,024 | $212,595 |
| 2021 | 14 | 1,418 | 2,400 | $829,249 | $204,111 |
| 2020 | 12 | 823 | 1,757 | $721,043 | $197,879 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 263 | 933 | $623,244 | $151,352 | 24.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 181 | 374 | $95,370 | $33,542 | 35.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 210 | 215 | $26,660 | $1,940 | 7.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 267 | 273 | $34,944 | $1,859 | 5.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 250 | 258 | $21,930 | $1,571 | 7.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $5,952 | $1,521 | 25.6% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 14 | 14 | $3,850 | $1,499 | 38.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 38 | 38 | $4,712 | $337.44 | 7.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 48 | 48 | $6,144 | $317.72 | 5.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 47 | 47 | $3,995 | $286.58 | 7.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 29 | 29 | $4,147 | $261.76 | 6.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 252 | 969 | $647,292 | $160,442 | 24.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 205 | 460 | $117,300 | $36,007 | 30.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 48 | $8,496 | $2,626 | 30.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $8,432 | $2,581 | 30.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 169 | 173 | $22,144 | $2,271 | 10.3% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 19 | 19 | $5,225 | $2,054 | 39.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 135 | 137 | $16,988 | $1,969 | 11.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 158 | 161 | $13,685 | $1,385 | 10.1% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 18 | 18 | $10,116 | $1,162 | 11.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 23 | 24 | $2,280 | $708.66 | 31.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 37 | 37 | $4,588 | $346.35 | 7.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 46 | 46 | $5,888 | $313.21 | 5.3% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 48 | 48 | $4,080 | $301.26 | 7.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 24 | 24 | $3,432 | $278.82 | 8.1% |
About Dr. Christopher Burdick, MD
Dr. Christopher Burdick, MD is a Neurocritical Care healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1396913745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Burdick, MD has received a total of $422.41 in payments from pharmaceutical and medical device companies, with $20.69 received in 2023. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($307.84).
As a Medicare-enrolled provider, Burdick has provided services to 4,807 Medicare beneficiaries, totaling 8,593 services with total Medicare billing of $809,070. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Neurocritical Care
- Other Specialties Internal Medicine, Critical Care Medicine
- Location San Antonio, TX
- Active Since 02/19/2008
- Last Updated 11/25/2025
- Taxonomy Code 2084A2900X
- Entity Type Individual
- NPI Number 1396913745
Products in Payments
- Impella (Device) $146.66
- ORENITRAM (Drug) $114.57
- BREZTRI (Drug) $20.69
- GIAPREZA (Drug) $19.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurocritical Care Doctors in San Antonio
Dr. Ali Seifi, Md, MD
Neurocritical Care — Payments: $126,680
Paola Martinez, M.d, M.D
Neurocritical Care — Payments: $856.87
Shaheryar Hafeez, Md, MD
Neurocritical Care — Payments: $363.49
Dr. Sorleen Trevino, Md, Mba, MD, MBA
Neurocritical Care — Payments: $291.57